DrugCite
Search

CLEXANE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Clexane Adverse Events Reported to the FDA Over Time

How are Clexane adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Clexane, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Clexane is flagged as the suspect drug causing the adverse event.

Most Common Clexane Adverse Events Reported to the FDA

What are the most common Clexane adverse events reported to the FDA?

Pulmonary Embolism
104 (3.28%)
Drug Exposure During Pregnancy
102 (3.22%)
Alanine Aminotransferase Increased
66 (2.08%)
Aspartate Aminotransferase Increase...
57 (1.8%)
Toxic Epidermal Necrolysis
49 (1.55%)
Stevens-johnson Syndrome
47 (1.48%)
Thrombocytopenia
46 (1.45%)
Hepatic Function Abnormal
44 (1.39%)
Myocardial Infarction
44 (1.39%)
Death
43 (1.36%)
Liver Injury
40 (1.26%)
Show More Show More
Drug Ineffective
38 (1.2%)
Pruritus
32 (1.01%)
Gamma-glutamyltransferase Increased
31 (.98%)
Anaemia
30 (.95%)
Haematoma
30 (.95%)
Haemorrhage
28 (.88%)
Haemoglobin Decreased
27 (.85%)
Renal Failure Acute
26 (.82%)
Blister
24 (.76%)
Gastrointestinal Haemorrhage
24 (.76%)
Nausea
24 (.76%)
Off Label Use
23 (.73%)
Seroma
23 (.73%)
Product Quality Issue
22 (.69%)
Pyrexia
22 (.69%)
Rash
21 (.66%)
Blood Alkaline Phosphatase Increase...
20 (.63%)
Renal Failure
20 (.63%)
Hypotension
19 (.6%)
Diarrhoea
17 (.54%)
Hyperkalaemia
17 (.54%)
Liver Function Test Abnormal
17 (.54%)
Oedema Peripheral
17 (.54%)
Abortion Spontaneous
16 (.5%)
Blood Bilirubin Increased
16 (.5%)
Post Procedural Haematoma
16 (.5%)
Deep Vein Thrombosis
15 (.47%)
Drug Interaction
15 (.47%)
Haemorrhage Intracranial
15 (.47%)
Jaundice
15 (.47%)
Transaminases Increased
15 (.47%)
Catheter Thrombosis
14 (.44%)
Chest Pain
14 (.44%)
Drug Exposure Via Breast Milk
14 (.44%)
Haematuria
14 (.44%)
Injection Site Haematoma
14 (.44%)
Neutropenia
14 (.44%)
Contusion
13 (.41%)
Dyspnoea
13 (.41%)
Headache
13 (.41%)
Leukopenia
13 (.41%)
Pneumonia
13 (.41%)
Thrombosis
13 (.41%)
Cardiac Failure Congestive
12 (.38%)
Dysgeusia
12 (.38%)
Hepatocellular Injury
12 (.38%)
International Normalised Ratio Incr...
12 (.38%)
Lip Erosion
12 (.38%)
Melaena
12 (.38%)
Atrial Fibrillation
11 (.35%)
Coronary Artery Thrombosis
11 (.35%)
Decreased Appetite
11 (.35%)
Erythema
11 (.35%)
Heparin-induced Thrombocytopenia
11 (.35%)
Hepatotoxicity
11 (.35%)
Abdominal Pain Upper
10 (.32%)
Cardiac Death
10 (.32%)
Cardiac Failure
10 (.32%)
Infection
10 (.32%)
Ischaemic Stroke
10 (.32%)
Loss Of Consciousness
10 (.32%)
Respiratory Failure
10 (.32%)
Shock Haemorrhagic
10 (.32%)
Vomiting
10 (.32%)
Caesarean Section
9 (.28%)
Fatigue
9 (.28%)
Hepatic Enzyme Increased
9 (.28%)
Hyponatraemia
9 (.28%)
Post Procedural Haemorrhage
9 (.28%)
Abortion Induced
8 (.25%)
Agranulocytosis
8 (.25%)
Apathy
8 (.25%)
Asthenia
8 (.25%)
Blood Cholesterol Increased
8 (.25%)
Cardiac Disorder
8 (.25%)
Epistaxis
8 (.25%)
Haematemesis
8 (.25%)
Haematocrit Decreased
8 (.25%)
In-stent Coronary Artery Restenosis
8 (.25%)
Injection Site Pain
8 (.25%)
Liver Disorder
8 (.25%)
Mixed Liver Injury
8 (.25%)
Multi-organ Failure
8 (.25%)
Pain
8 (.25%)
Renal Impairment
8 (.25%)
Retroperitoneal Haemorrhage
8 (.25%)
Sepsis
8 (.25%)
Swelling Face
8 (.25%)
Urinary Tract Infection
8 (.25%)
Abdominal Pain
7 (.22%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Clexane, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Clexane is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Clexane

What are the most common Clexane adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Clexane, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Clexane is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Clexane According to Those Reporting Adverse Events

Why are people taking Clexane, according to those reporting adverse events to the FDA?

Thrombosis Prophylaxis
374
Drug Use For Unknown Indication
195
Prophylaxis
128
Product Used For Unknown Indication
109
Deep Vein Thrombosis
65
Pulmonary Embolism
62
Show More Show More
Anticoagulant Therapy
55
Thrombosis
42
Atrial Fibrillation
37
Acute Coronary Syndrome
31
Thrombophlebitis
22
Coagulopathy
13
Myocardial Infarction
12
Acute Myocardial Infarction
12
Phlebitis
9
Hepatic Vein Thrombosis
8
Abdominal Operation
7
Angina Unstable
7
Surgery
6
Femoral Neck Fracture
6
Antiphospholipid Syndrome
6
Hip Arthroplasty
6
Coronary Artery Disease
5
Immobile
5
Atrial Flutter
5
Deep Venous Thrombosis Prophylaxis
4
Infarction
4
Hip Fracture
4
Aortic Valve Replacement
4
Cerebrovascular Disorder
4
Vena Cava Thrombosis
4
Hypercoagulation
4
Arterial Stenosis
4
Pregnancy
3
Hypotension
3
Cardiac Pacemaker Insertion
3
Multiple Myeloma
3
Cerebral Infarction
3
Venous Thrombosis
3
Postoperative Thrombosis
3
Percutaneous Coronary Intervention
3
Stent Placement
3
Bladder Operation
3
Knee Arthroplasty
3
Osteoarthritis
2
In Vitro Fertilisation
2
Paraplegia
2
Embolism
2
Bronchoscopy
2
Varicose Vein
2
Polycythaemia Vera
2

Clexane Case Reports

What Clexane safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Clexane. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Clexane.